(Q39117420)

9 September 2017

title

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells (English)

1 reference

9 September 2017

0 references

1 reference

hepatitis C virus

1 reference

Che C Colpitts

2

0 references

Philip Meuleman

object named as

Philip Meuleman

12

0 references

Eike Steinmann

object named as

Eike Steinmann

16

0 references

Charles M. Rice

13

object named as

Charles M Rice

1 reference

9 September 2017

14

Alexander Ploss

1 reference

9 September 2017

6

Stephanie Pfaender

1 reference

9 September 2017

3

Luis M Schang

1 reference

9 September 2017

9

Dorothea Bankwitz

1 reference

9 September 2017

7

Patrick Behrendt

1 reference

9 September 2017

Anggakusuma

1

1 reference

9 September 2017

Heni Rachmawati

4

1 reference

9 September 2017

Anne Frentzen

5

1 reference

9 September 2017

Richard J P Brown

8

1 reference

9 September 2017

Joerg Steinmann

10

1 reference

9 September 2017

Michael Ott

11

1 reference

9 September 2017

Thomas Pietschmann

15

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

9 September 2017

1 reference

9 September 2017

volume

63

1 reference

9 September 2017

issue

7

1 reference

9 September 2017

page(s)

1137-1149

1 reference

Evolving epidemiology of hepatitis C virus

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Viral hepatitis and liver cancer: the case of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Cellular and molecular biology of HCV infection and hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Treating viral hepatitis C: efficacy, side effects, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Retransplantation in patients with hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Glucocorticosteroids increase cell entry by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

A novel small molecule inhibitor of hepatitis C virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Griffithsin has antiviral activity against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Bile acids specifically increase hepatitis C virus RNA-replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Influence of membrane fluidity on human immunodeficiency virus type 1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

A genetically humanized mouse model for hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Flip-flop: the transmembrane translocation of lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Magnetic resonance studies of eukaryotic cells. III. Spin labeled fatty acids in the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Membrane “fluidity” as detected by diphenylhexatriene probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-304299

Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT.

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1136/GUTJNL-2012-304299

Effects of calcium, lanthanum, and temperature on the fluidity of spin-labeled human platelets

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1136/GUTJNL-2012-304299

Identifiers

DOI

10.1136/GUTJNL-2012-304299

1 reference

9 September 2017

1 reference